Dashboard
Discussions
Watchlists
Collections
Tools
More
Events
SIGN UP
SIGN IN
ENTITY
Samsung Biologics (207940 KS)
Watchlist
315
Analysis
Health Care
•
South Korea
Samsung Biologics Co.,Ltd. manufactures bio-healthcare products. The Company develops, refines, and distributes biopharmaceutical products.
more
Watchlist
All
Insights
Broker
Sponsored
Syndicated
Podcast
Buy side
Refresh
Focused
Suggested
bullish
•
Samsung SDI
•
26 Feb 2022 06:28
FnGuide Samsung Group Index Rebalancing Preview
FnGuide Samsung Group Index has the largest AUM among the locally-themed indexes. This post previews the upcoming rebalancing in June.
Sanghyun Park
Follow
365 Views
Share
bullish
•
LG Energy Solution
•
02 Feb 2022 18:57
KRX New Deal Index Rebalance Preview (March): More Flow for LG Energy
There are many changes to the KRX New Deal indices at the March rebal. The largest inflow is on LG Energy. The largest buying impact is on...
Brian Freitas
Follow
372 Views
Share
bullish
•
Soop
•
02 Feb 2022 07:42
KRX K-New Deal Index Screening Period Ended: Rebalancing Changes & Passive Impacts Update
The KRX K-New Deal Index's screening period ended last Friday. This post updates the screening results and passive impacts.
Sanghyun Park
Follow
248 Views
Share
bearish
•
Samsung Biologics
•
01 Feb 2022 01:32
Samsung Biologics: Rights Offering of 3 Trillion Won to Acquire Remaining Stake in Samsung Bioepsis
Despite the long-term positive prospects of consolidating results from Samsung Bioepsis, we believe the acquisition price was a bit too high at...
Douglas Kim
Follow
426 Views
Share
bullish
•
Samsung Biologics
•
31 Jan 2022 03:12
Samsung Biologics Offering: Deal Summary & Trading Dynamics
Samsung Biologics announced that it would purchase all of Samsung Bioepis shares owned by Biogen. So, it also announced a ₩3T rights offering. This...
Sanghyun Park
Follow
360 Views
Share
First
Previous
18
19
20
21
22
23
24
Next
Last
Copyright © 2022 Smartkarma Innovations Pte Ltd. All Rights Reserved. v3.37.2
x